| Date | Events, Presentations & Webcasts |
|---|---|
| Nov. 10, 2022 | Capricor Therapeutics Third Quarter 2022 Financial Results and Corporate Update Conference Call |
| Oct. 14, 2022 | One-Year Results from HOPE-2 Open Label Extension Study Presented at World Muscle Society 2022 – Nova Scotia, Canada |
| Sept. 13, 2022 | Capricor’s Presentation at the H.C. Wainwright 24th Annual Global Investment Conference – Webcast |
| Aug. 10, 2022 | Capricor Therapeutics Second Quarter 2022 Financial Results and Corporate Update Conference Call |
| Jun. 27, 2022 | Capricor HOPE-2 OLE Data – Webcast and Slide Presentation |
| Oct. 22, 2021 | Webcast with BioPub Research – Webcast |
| Sept. 24, 2021 | HOPE-2 – One Year Results Data Call – Webcast and Slides |
| Jun. 22, 2021 | Capricor Therapeutics Presentation at Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference. – Video |
| May 29, 2021 | White House Chronicle, “Hurdles for innovative drug development at small biotech companies” featuring Capricor’s ,CEO, Linda Marbàn – Video |
| May 18, 2021 | Capricor Presentation at 10th Annual ISEV Virtual Meeting 2021 – Poster |
| Aug. 5, 2020 | White House Chronicle, “Developing exosomal therapies for diseases” featuring Capricor’s ,CEO, Linda Marbàn – Video |
| Jul. 30, 2020 | CEO Spotlight Call: Exosomes Panel, Hosted by LifeSci Advisors – Webcast |
| Jun. 16, 2020 | The Big Biz Show: Interview Segment 1 and Segment 2 |
| Apr. 17, 2020 | Webcast with BioPub Research – Webcast |
| Apr. 15, 2020 | KOL Call on Cardiac Complications of Duchenne Muscular Dystrophy (DMD) – Webcast and Slide Presentation |
| Mar. 26, 2020 | KOL Call on Why Exosomes are Uniquely Suited for Vaccine Development – Webcast and Slide Presentation |
Capricor is excited to share insights on opportunities we are exploring. Hear from our key leaders to learn more about the work that makes us unique.
For Archived Events and Presentations click here